Patient Monitoring during Treatment with Ocrelizumab and Rituximab (ORP-49)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Nazanin Razazian


Current Updates on the Use of Probiotics as a New Treatment Option for Multiple Sclerosis (ORP-50)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Adrina Habibzadeh; Sara Dehghani; Samin Shiati


Management of seizure in patients with multiple sclerosis (ORP-51)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Ali Akbar Asadi-Pooya


The role of stereotactic biopsy in atypical brain lesions (ORP-52)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Sohrab Shahzadi


Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Saba Naghavi; Fereshteh Ashtari; Aryan Kavosh; Ahmad Pourmohammadi; Iman Adibi; Arshia Ghalamkari; Zahra Karimi


System biology review of multiple sclerosis and discovery of drug targets (ORP-54)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Ali Alizadeh Amiri


Spinal cord MRI in multiple sclerosis; diagnostic, prognostic, and clinical value (ORP-55)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Vahid Shaygannejad


Neuromyelitis Optica Spectrum Disorders (NMOSD); Diagnostic criteria (ORP-56)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Maryam Poursadeghfard


Optic neuritis updates (ORP-57)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Nahid Beladi Moghadam


A middle-aged woman with history of Multiple sclerosis presented with sub-acute encephalopathy (ORP-58)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Sanaz Heydari


Reduction in Circulating Vitamin D Binding Protein in Patients with Multiple sclerosis (ORP-59)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Zhila Maghbooli


Multiple Sclerosis (MS) and Legal Medical Doctrines (ORP-60)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Reza Hajmanouchehri


MS and Environmental Factors (ORP-61)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Mehdi Moghadasi


Care ethics and empathic Practices in dealing with MS Patients (ORP-62)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Hanieh Zaer Rezaei


The effects of crocin on inflammatory biomarkers and mental health in patients with multiple sclerosis: a randomized, double-blinded clinical trial (ORP-63)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Ebrahim Kouchaki; Nasim Safa


What should we do to reduce the complications of Deep brain stimulation in Parkinson's disease?

Volume 1, Issue 1, June 2022, Pages 1-11

10.52547/nl.1.1.1

Fardin Nabizadeh


Review Current and Emerging Treatment Options for Alzheimer's Disease

Volume 2, Issue 1, April 2023, Pages 1-5

10.52547/nl.2.1.1

Dimple Kumar Vats; Nistara Biswas; Preethi Pandian; Anupam Kamalakannan


Proposing Strategies to Increase Pregnancy-Related Awareness Among Multiple Sclerosis Patients in Iran

Volume 3, Issue 1, January 2024, Pages 1-2

10.61186/nl.3.1.1

Elnaz Asadollahzadeh; Sam Daneshvar


The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine

Volume 3, Issue 1, January 2024, Pages 3-11

10.61186/nl.3.1.3

Mohammad Balabandian; Mobin Mohammadi; Arashk Mallahzadeh


Quantitative Electroencephalography Findings in Treatment-resistant and Responsive Patients with Idiopathic Generalized Tonic-Clonic Epilepsy

Volume 2, Issue 1, April 2023, Pages 6-12

10.52547/nl.2.1.6

Sheida Shaafi; Seyede Maryam Nasibi; Gholamreza Chalabianloo; Seyed Aria Nejadghaderi


Biomaterials in The Treatment of Amyotrophic Lateral Sclerosis

Volume 1, Issue 1, June 2022, Pages 12-16

10.52547/nl.1.1.12

Fardin Nabizadeh


Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study

Volume 3, Issue 1, January 2024, Pages 12-19

10.61186/nl.3.1.12

Behnaz Moradi; Fatemeh Zare Bidoki; Javid Azadbakht; Mahboobeh Shirazi; Hassan Hashemi; Sedigheh Hantooshzadeh; Mohamad Ali Kazemi; Mohammad Shafiee; Mohammad Hossein Golezar


Guillain-Barré syndrome in remission of Ulcerative colitis: a case report

Volume 2, Issue 1, April 2023, Pages 13-15

10.52547/nl.2.1.13

Maedeh Khodkam; Delaram Panahi


Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease

Volume 2, Issue 1, April 2023, Pages 16-24

10.52547/nl.2.1.16

Fardin Nabizadeh; Mohammad Balabandian; Mohammad Reza Rostami; Soraya Mehrabi; Mohsen Sedighi


Neuroimmunoactive biomaterial design

Volume 1, Issue 1, June 2022, Pages 17-18

10.52547/nl.1.1.17

Maedeh Khodkam